Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
This study is enrolling participants by invitation only.
Study NCT00660335   Information provided by Repligen Corporation
First Received: April 15, 2008   Last Updated: January 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pancreatitis
More general conditions related to this trial
Digestive System Diseases
Pancreatic Diseases
Interventions listed in this trial
RG1068 (synthetic human secretin)
Additional drug interventions recognized in this trial
Secretin
More general drug interventions related to this trial
Gastrointestinal Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Repligen Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services